Sumitomo Mitsui Trust Holdings, Inc. - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 230 filers reported holding NOVOCURE LTD in Q3 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.

Quarter-by-quarter ownership
Sumitomo Mitsui Trust Holdings, Inc. ownership history of NOVOCURE LTD
ValueSharesWeighting
Q2 2023$9,646,053
-40.2%
232,435
-13.3%
0.01%
-33.3%
Q1 2023$16,118,422
-17.6%
268,015
+0.5%
0.01%
-20.0%
Q4 2022$19,558,337
-4.7%
266,644
-1.3%
0.02%
-11.8%
Q3 2022$20,532,000
+10.7%
270,225
+1.3%
0.02%
+21.4%
Q2 2022$18,541,000
-13.2%
266,777
+3.5%
0.01%0.0%
Q1 2022$21,362,000257,8440.01%
Other shareholders
NOVOCURE LTD shareholders Q3 2023
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 350,884$26,344,0008.01%
HARTLINE INVESTMENT CORP/ 318,109$23,884,0003.27%
Deep Track Capital, LP 550,000$41,294,0002.92%
MORGAN JESS S & CO INC 43,975$3,302,0002.03%
Taylor Frigon Capital Management LLC 46,376$3,482,0001.09%
Darsana Capital Partners LP 258,937$19,441,0000.90%
Private Harbour Investment Management & Counsel, LLC 13,562$1,018,0000.81%
Rhenman & Partners Asset Management AB 120,387$9,610,0000.64%
COURAGE CAPITAL MANAGEMENT LLC 10,000$751,0000.50%
Baillie Gifford 9,615,168$721,906,0000.40%
View complete list of NOVOCURE LTD shareholders